Efficacy of immunization of high-risk infants against hepatitis B virus evaluated by polymerase chain reaction

Journal of Medical Virology

Volumn 53, Issue 3, 1997, Pages 255-260

  Matsumoto, Takehiro ^a   Nakata, Keisuke ^a   Hamasaki, Keisuke ^a   Daikokoku, Manabu ^a   Nakao, Kazuhiko ^a   Yamashita, Yoshifumi ^b   Shirahama, Satoshi ^b   Kato, Yuji ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Kamigoto Hospital   (Japan)

Author keywords

HBV DNA; Hepatitis B vaccine; PCR

Indexed keywords

HEPATITIS B VACCINE;

ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INFANT; INFECTION PREVENTION; MALE; POLYMERASE CHAIN REACTION; TREATMENT FAILURE; VIRUS GENE;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0031409474     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199711)53:3<255::AID-JMV13>3.0.CO;2-G     Document Type: Article

References (38)

1. Beasley RP (1988): Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61:1942-1956.
2. Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, Chen CL (1983): Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 2:1099-1102.
3. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC (1990): Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329.
4. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R (1995): Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 345:1406-1407.
5. Eto T, Shiraki K (1989): National project on the prevention of mother-to-infant infection by hepatitis B virus in Japan. Acta Paediatrica Japonica 31:681-684.
6. Fujii H, Moriyama K, Sakamoto N, Kondo T, Yasuda K, Hiraizumi Y, Yamazaki M, Sakaki Y, Okochi K, Nakajima E (1992): Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochemical and Biophysical Research Communications 184:1152-1157.
7. Hamasaki K, Nakata K, Nagayama Y, Ohtsuru A, Daikoku M, Taniguchi K, Tsutsumi T, Sato Y, Kato Y, Nagataki S (1994): Changes in the prevalence of HBeAg-negative mutant hepatitis B virus during the course of chronic hepatitis B. Hepatology 20:8-14.
8. Hino K, Okuda M, Hashimoto O, Ishiko H, Okazaki M, Fujii K, Hanada H, Okita K (1995): Glycine-to-arginine substitution at codon 145 of HBsAg in two infants born to hepatitis B e antigen-positive carrier. Digestive Diseases and Sciences 40:566-570.
9. Hou J, Karayiannis P, Waters J, Luo K, Liang C, Thomas HC (1995): A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers. Hepatology 21:273-278.
10. Inokuchi K, Nakata K, Hamasaki K, Daikoku M, Nakao K, Kato Y, Yatsuhashi H, Koga M, Yano M, Nagataki S (1996): Prevalence of hepatitis B or C virus infection in patients with fulminant viral hepatitis. An analysis using polymerase chain reaction. Journal of Hepatology 24:258-264.
11. Itoh Y, Takai E, Ohnuma H, Kitajima K, Tsuda F, Machida A, Mishiro S, Nakamura T, Miyakawa Y, Mayumi M (1986): A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: Protective efficacy in chimpanzees. Proceedings of the National Academy of Sciences USA 83:9174-9178.
12. Kamito H, Nakata K, Hamasaki K, Daikoku M, Mawatari F, Ueki T, Hayashida Y, Nakao K, Kato Y, Nagataki S (1996): Detection of hepatitis B virus genome in hepatocellular carcinoma from both hepatitis B surface antigen- and antibody to hepatitis C virus-negative patients: A study using polymerase chain reaction. Oncology Reports 3:619-623.
13. Kaneko S, Miller RH, Feinstone SM, Unoura M, Kobayashi K, Hattori N, Purcell RH (1989): Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proceedings of the National Academy of Sciences USA 86:312-316.
14. Karthigesu VD, Allison LM, Fortuin M, Mendy M, Whittle HC, Howard CR (1994): A novel hepatitis B virus variant in the sera of immunized children. Journal of General Virology 75:443-448.
15. Kato J, Hasegawa K, Torii N, Yamauchi K, Hayashi N (1996): A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B. Hepatology 23:389-395.
16. Kato Y, Nakata K, Omagari K, Furukawa R, Kusumoto Y, Mori I, Tajima H, Tanioka H, Yano M, Nagataki S (1994): Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer 74:2234-2238.
17. Koff RS (1993): Viral hepatitis. In Schiff L, Schiff ER (eds): "Disease of the Liver." 7th Ed. Philadelphia: JB Lippincott, pp 514-516.
18. Kuhns M, McNamara A, Mason A, Campbell C, Perrillo R (1992): Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen. Gastroenterology 103:1649-1656.
19. Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA (1995): Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. Journal of the American Medical Association 274:1201-1208.
20. Marion SA, Tomm Pastore M, Pi DW, Mathias RG (1994): Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. American Journal of Epidemiology 140:734-746.
21. Matsuo A, Kusumoto Y, Ohtsuka E, Ohtsuru A, Nakamura Y, Tajima H, Shima M, Nakata K, Muro T, Satoh A, Ishii N, Koji T, Nagataki S (1990): Changes in HBsAg carrier rate in Goto Islands, Nagasaki Prefecture, Japan. Lancet 335:955-957.
22. Milich DR, McNamara MK, McLachlan A, Thornton GB, Chisari FV (1985a): Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region. Proceedings of the National Academy of Sciences USA 82: 8168-8172.
23. Milich DR, Thornton GB, Neurath AR, Kent SB, Michel ML, Tiollais P, Chisari FV (1985b): Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science 228:1195-1199.
24. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A (1990): Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proceedings of the National Academy of Sciences USA 87:6599-6603.
25. Neurath AR, Kent SB, Parker K, Prince AM, Strick N, Brotman B, Sproul P (1986): Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing. Vaccine 4:35-37.
26. 127) of hepatitis B virus. International Hepatology Communications 6:158-165.
27. Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K, Tsuda F, Machida A, Mishiro S (1992): Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatric Research 32:264-268.
28. Oon CJ, Lim GK, Ye Z, Goh KT, Tan KL, Yo SL, Hopes E, Harrison TJ, Zuckerman AJ (1995): Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 13:699-702.
29. Oon CJ, Tan KL, Harrison T, Zuckerman A (1996): Natural history of hepatitis B surface antigen mutants in children. Lancet 348:1524.
30. Soulie JC, Devillier P, Santarelli J, Goudeau A, Vermeulen P, Guellier M, Saliou P, Hillion AM, Tron F, Huchet J (1991): Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens. Vaccine 9:545-548.
31. Stevens CE, Taylor PE, Tong MJ, Toy PT, Vyas GN, Nair PV, Weissman JY, Krugman S (1987): Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. Journal of American Medical Association 257:2612-2616.
32. Sumazaki R, Motz M, Wolf H, Heinig J, Jilg W, Deinhardt F (1989): Detection of hepatitis B virus in serum using amplification of viral DNA by means of the polymerase chain reaction. Journal of Medical Virology 27:304-308.
33. Whittle HC, Maine N, Pilkington J, Mendy M, Fortuin M, Bunn J, Allison L, Howard C, Hall A (1995): Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet 345:1089-1092.
34. Wong VC, Ip HM, Reesink HW, Lelie PN, Reerink-Brongers EE, Yeung CY, Ma HK (1984): Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet 1:921-926.
35. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H, Miyakawa Y, Mayumi M (1994): Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. Journal of Virology 68:2671-2676.
36. Zaman SN, Melia WM, Johnson RD, Portmann BC, Johnson PJ, Williams R (1985): Risk factors in development of hepatocellular carcinoma in cirrhosis: Prospective study of 613 patients. Lancet 1: 1357-1360.
37. Zhang YY, Hansson BG, Kuo LS, Widell A, Nordenfelt E (1993): Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg. Hepatology 17:538-544.
38. Zuckerman AJ, Harrison TJ, Oon CJ (1994): Mutations in S region of hepatitis B virus. Lancet 343:737-738.